Preparative regimens used in bone marrow transplantation usually result in impairment of male fertility. Although recovery of fertility is more likely after chemotherapy-based regimens, this is a rare occurrence after TBI containing regimens. We undertook a crosssectional study of recovery of spermatogenesis in men who had undergone allogeneic and autologous marrow or peripheral stem cell transplant between 1984 and 1995. We identified six out of 42 patients eligible for analysis to have either recovered fertility or spermatogenesis. Seminal fluid analysis showed that four out of 25 patients recovered sperm counts. This has important implications for patient counselling, post-transplant follow-up and contraceptive advice. Keywords: BMT; spermatogenesis; fertility; TBI Conditioning regimens which include total body irradiation (TBI) and cyclophosphamide (CY) generally render male patients sterile after bone marrow transplantation.
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Although rare, men can recover fertility after TBI/CY conditioning resulting in successful pregnancy. [1] [2] [3] We did a cross-sectional study of recovery of spermatogenesis in all surviving male patients who had undergone allogeneic or autologous (ABMT) bone marrow or peripheral stem cell transplantation (PBSCT) at the Birmingham University Hospital between 1984 and 1995.
Patients and methods
Forty-six patients were identified and invited to participate in the study. Seminal fluid analysis on freshly produced samples was performed on a single occasion by the department of Andrology, Birmingham Maternity Hospital. Since this is a cross-sectional study to look at recovery of spermatogenesis, gonadotrophic hormone and testosterone estimations were not performed. except in the case of aplastic anaemia (Patient 3) where CY was given at 50 mg/kg for 4 days without irradiation. TBI, prior to 1992, was delivered in a perspex tank with lateral opposing portals with the patients in a semi-supine position with air gaps filled with bolus. Irradiation was derived from a Cobalt source treating at an extended distance, giving a midpoint mediastinal dose of 9.5 Gy, at a dose rate of approximately 5 cGy/min (0.05 Gy/min). The calculated dose to the testes is 7.7 Gy delivered at a dose rate of 3.3 cGy min (0.033 Gy/min). Fractionated radiotherapy was introduced in 1992 providing a total dose of 14.4 Gy in 8 fractions given twice daily over 4 days, with a minimum inter-fraction interval of 8 h. The mean total dose to the testes is 12.1 Gy. This was initially delivered using a Cobalt unit at a dose rate of 0.05 Gy/min and subsequently using a linear accelerator at a dose rate of approximately 0.09 Gy/min. Patients undergoing ABMT or autologus PBSCT for lymphoma were conditioned with chemotherapy alone using a combination of carmustine, etoposide, cytosine arabinoside and melphalan (BEAM), having had a variety of treatments previously. Two patients with AML received a preparative regimen with CY, doxorubicin, 6-thioguanine, BCNU and Ara-C.
Results
Of the 46 patients identified, four were excluded due to previous vasectomy, 16 declined testing and one could not produce a sample. Samples from 25 patients were available for analysis. Twelve patients had undergone allogeneic BMT, including one matched unrelated donor transplant (MUD), and 13 autologous transplants (eight ABMT, five auto-PBSC). Conditioning regimens are detailed in Table 1 . Age at transplantation ranged from 17 to 53 years (median 31, mean 31.4 years). Post-transplant follow-up ranged from 1-111 months at the time of seminal fluid analysis, with a mean and median of 40.2 and 41 months, respectively.
Four out of 25 patients had documented recovery of normal sperm counts; one having had an allogeneic BMT for aplastic anaemia following conditioning with CY alone; and three patients with AML, one of whom received an allogeneic BMT following CY/TBI and the other two received chemotherapy conditioning as described above. The patient who had TBI conditioning received 9.5 Gy single fraction radiotherapy. Recovery of sperm count was documented 67, 75, 68 and 50 months, respectively post transplant at the time of seminal fluid analysis.
Two of the patients who declined testing had successfully fathered children -one after allogeneic BMT following CY-TBI conditioning for CGL as previously reported 3 ; motility medium/good; motile sperm Ͼ50%; live sperm Ͼ75%; normal sperm Ͼ30%; progressive motile normal sperm Ͼ4. and the other after ABMT following conditioning with CY, doxorubincin, 6-thioguanine, BCNU, Ara-C for AML.
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In total we identified six patients out of 46 who recovered fertility or spermatogenesis. Two of these patients were reported previously. 
Discussion
Post-pubertal use of high-dose myeloablative therapy with TBI generally causes permanent gonadal damage after marrow transplantation. 4 Recovery of gonadal function following marrow transplant, however, does occur in most patients who receive CY only conditioning for severe aplastic anaemia (SAA) but only in a small number of patients after the use of preparative regimens which include TBI. [1] [2] [3] [4] [5] In addition, other factors such as age, sex, pubertal status, primary disease, type of transplantation and previous chemotherapy which influence the degree of gonadal damage may affect eventual recovery. 6 Age as a factor for recovery of fertility appears to be less important in men than in women. 1, 7, 8 Recovery of fertility after BMT has been reported in men who were in their thirties and forties at the time of transplant. [1] [2] [3] In this study, the age of patients who recovered spermatogenesis ranges from 21 to 41 years at the time of transplant. One patient in this study who recovered fertility after TBI was 33 years at the time of transplant and 39 when he was found to have recovered fertility following his wife's pregnancy.
Alkylating agents can cause prolonged, if not permanent, testicular dysfunction. CY is believed to be more toxic when combined with busulphan. 6 Recovery, however, has occurred even when these two drugs were used together. 9 Patients undergoing treatment with anthracyclines and antimetabolites for acute leukaemia are reported to have had normal gonadotrophic hormone levels. 10 Three of the four of our patients who recovered spermatogenesis had previous chemotherapy for AML according to the Medical Research Council Trial protocol. One of these patients received TBI and the other two received chemotherapy conditioning which contained CY, doxorubicin, carmustine, 6-thioguanine and Ara-C as part of their preparative regimen.
Pregnancy or recovery of gonadal function is reported less often after autologous transplants for lymphoma. 11 None of the patients in this study who had autologous BMT or auto-PBSCT for lymphoma has recovered fertility (mean age Ͻ32 years, mean follow-up 31 months). Previous prolonged treatment with alkylating agents or the primary disease itself, especially in Hodgkin's disease, may account for this difference. 10 Radiation-induced tissue damage depends on the total dose received, dose fractionation, dose rate and dose distribution. 12 Radiation-induced testicular damage, in addition, depends on the stage of spermatogenesis exposed to radiation. 13 Although recovery of testicular function resulting in successful pregnancies after TBI is much less frequent than after chemotherapy only conditioning, a number of pregnancies have been reported after TBI. [1] [2] [3] 14 In this study, only one patient who received unfractionated TBI of 9.5 Gy was confirmed to have recovered his sperm count. Only a few pregnancies have been reported in partners of men who had fractionated TBI which is believed to cause less late toxicity and immunosuppression compared with single-dose TBI. 12 The reported highest dose of TBI where recovery of fertility occurred in men is 15.75 Gy given over 7 days. 15 Time from transplant to recovery of gonadal function may be shorter for men who did not receive TBI, with recovery occurring as early as 15 and 19 months post transplant. 1, 11 The two AML patients and one SAA patient in this study who did not receive TBI were confirmed to have recovered their sperm counts 50, 68 and 67 months, respectively after transplant. Most reported pregnancies after TBI occurred 4 or more years following transplant. A patient in this study who recovered spermatogenesis after TBI was 75 months post-transplant at the time of seminal fluid analysis. Since this is a cross-sectional study it is not possible to ascertain how long after transplant these patients recovered gonadal function. The longest follow-up for fractionated TBI in this study was only 35 months which may not be long enough to assess recovery.
Sanders et al 1 reported 146 pregnancies in 76 transplant recipients which showed that congenital abnormalities are rare following bone marrow transplantation. Pregnancy in women TBI recipients, however, was associated with increased pregnancy-related complications. 15 Pregnancies in transplant recipients or in their partners often result in medical termination of pregnancy due to the unplanned nature of the pregnancy and concerns regarding teratogenic effect of chemotherapy and radiotherapy. 6 The pregnancy in the partner of one of our patients, previously reported, showed a normal karyotype on limited chromosome analysis after medical termination of pregnancy due to concerns regarding the teratogenic effect of previous treatment. 3 These data have important implications for pre-transplant counselling and contraceptive advice. Since the chance of recovery of fertility after transplant is small and unpredictable, except in cases of SAA, all eligible patients including those who are sub-fertile should be offered pre-treatment semen analysis, and, if appropriate, semen or embryo cryopreservation. 6 Post-transplant counselling should include appropriate contraceptive measures if pregnancy is to be avoided. Gonadotrophic hormonal estimation should be part of routine posttransplant endocrine assessment even in those who do not want any more children to decide the timing for seminal fluid analysis for appropriate contraceptive advice. In those who do recover fertility resulting in pregnancy, the risk of congenital abnormalities in children do not appear to be any different from the general population.
